Camp4 Therapeutics (CAMP) Profit After Tax (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Profit After Tax data on file, last reported at -$18.3 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax changed N/A year-over-year to -$18.3 million; the trailing twelve-month figure through Mar 2026 stood at -$86.3 million (down 119.32% YoY), and the FY2025 full-year result was -$80.4 million, down 55.25% from the prior year.
• Profit After Tax climbed to -$18.3 million in Q1 2026, from -$40.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$11.7 million in Q3 2023 to a low of -$40.3 million in Q4 2025.
• A 4-year average of -$16.3 million and a median of -$13.1 million in 2023 frame the typical range for Profit After Tax.
• Peak annual rise in Profit After Tax reached 0.12% in 2025, while the deepest fall reached 203.37% in 2025.
• Tracing CAMP's Profit After Tax over 4 years: stood at -$13.0 million in 2023, then fell by 2.22% to -$13.3 million in 2024, then plunged by 203.37% to -$40.3 million in 2025, then jumped by 54.57% to -$18.3 million in 2026.
• Business Quant data shows CAMP's Profit After Tax at -$18.3 million in Q1 2026, -$40.3 million in Q4 2025, and -$15.1 million in Q3 2025.